Literature DB >> 8759844

Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.

P S Hoffman1, A Goodwin, J Johnsen, K Magee, S J Veldhuyzen van Zanten.   

Abstract

In this study, we compared metronidazole (Mtz)-sensitive and -resistant strains of Helicobacter pylori for metabolic differences that might correlate with drug resistance. Included in this study was an isogenic Mtz(r) strain, HP1107, that was constructed by transforming genomic DNA from Mtz(r) strain HP439 into Mtz(s) strain HP500. Enzyme activities were also measured for Mtz(r) strains grown in the presence or absence of 18 micrograms of metronidazole per ml (ca. one-half of the MIC). These studies confirmed the presence of the Embden-Meyerhof-Parnas, Entner-Doudoroff, and pentose pathways. H. pylori strains expressed enzymatic activities indicative of a complete and active Krebs cycle. All strains expressed pyruvate oxidoreductase (POR) and alpha-ketoglutarate oxidoreductase (KOR) as measured with the redox-active dye benzyl viologen (30 to 96 nmol/min/mg of protein for POR and 30 nmol/min/mg of protein for KOR). When grown in the presence of Mtz at > or = 3.5 micrograms/ml, Mtz(r) strains expressed no detectable POR or KOR activity. The apparent repression of POR and KOR activities by Mtz affected bacterial growth as manifest by extended lag periods and growth yield reductions of > 30%. A dose-dependent relationship was demonstrated between the metronidazole concentration in the growth medium and the specific activity of POR measured in bacterial cell extracts. The observed repression was not due to inactivation of POR by Mtz. In addition to repression of POR and KOR activities, growth in the presence of Mtz also led to decreases in the activities of various Krebs cycle enzymes, including aconitase, isocitrate dehydrogenase and succinate dehydrogenase. All of the Mtz(r) strains examined expressed isocitrate lyase and malate synthase activities indicative of the glyoxylate bypass. No isocitrate lyase activity was detected in Mtz(s) strain HP500. Isocitrate lyase activity was expressed by HP500 following transformation to Mtz resistance (Mtz(r) strain HP1107) with DNA from an Mtz(r) strain. The results of this study suggest that Mtz resistance may be a recessive trait, possibly involving inactivation of a regulatory gene, that results in constitutive expression of isocitrate lyase. Repression of POR and KOR activities in response to low levels of Mtz may be a general response of H. pylori strains to Mtz, but only resistant strains manage to survive via activation of compensatory metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759844      PMCID: PMC178263          DOI: 10.1128/jb.178.16.4822-4829.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  44 in total

1.  THE EFFECT OF ADENYLIC ACID ON YEAST NICOTINAMIDE ADENINE DINUCLEOTIDE ISOCITRATE DEHYDROGENASE, A POSSIBLE METABOLIC CONTROL MECHANISM.

Authors:  J A HATHAWAY; D E ATKINSON
Journal:  J Biol Chem       Date:  1963-08       Impact factor: 5.157

2.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  Purification and properties of a specific fructose 1,6-diphosphatase from Candida utilis.

Authors:  O M Rosen; S M Rosen; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1965-12       Impact factor: 4.013

4.  Nutritional requirements for growth of Helicobacter pylori.

Authors:  P Nedenskov
Journal:  Appl Environ Microbiol       Date:  1994-09       Impact factor: 4.792

5.  Studies of the microaerophilic nature of Campylobacter fetus subsp. jejuni. I. Physiological aspects of enhanced aerotolerance.

Authors:  P S Hoffman; N R Krieg; R M Smibert
Journal:  Can J Microbiol       Date:  1979-01       Impact factor: 2.419

6.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

Authors:  M A Smith; D I Edwards
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

8.  Pyruvate oxidation by the Reiter strain of Treponema phagedenis.

Authors:  H A George; R M Smibert
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

9.  Mode of action of metronidazole on anaerobic bacteria and protozoa.

Authors:  M Müller
Journal:  Surgery       Date:  1983-01       Impact factor: 3.982

10.  Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori.

Authors:  S L Lacey; S F Moss; G W Taylor
Journal:  J Antimicrob Chemother       Date:  1993-09       Impact factor: 5.790

View more
  41 in total

1.  Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains.

Authors:  N M Solcà; M V Bernasconi; J C Piffaretti
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Characterization of a ComE3 homologue essential for DNA transformation in Helicobacter pylori.

Authors:  Yu-Ching Yeh; Tzu-Lung Lin; Kai-Chih Chang; Jin-Town Wang
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Genome-scale metabolic model of Helicobacter pylori 26695.

Authors:  Christophe H Schilling; Markus W Covert; Iman Famili; George M Church; Jeremy S Edwards; Bernhard O Palsson
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

Review 4.  Lipoic acid metabolism in microbial pathogens.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

5.  Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis.

Authors:  A F Chalker; H W Minehart; N J Hughes; K K Koretke; M A Lonetto; K K Brinkman; P V Warren; A Lupas; M J Stanhope; J R Brown; P S Hoffman
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects.

Authors:  Igor N Olekhnovich; Serhiy Vitko; Olga Chertihin; Raquel Hontecillas; Monica Viladomiu; Josep Bassaganya-Riera; Paul S Hoffman
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

7.  Another unusual type of citric acid cycle enzyme in Helicobacter pylori: the malate:quinone oxidoreductase.

Authors:  B Kather; K Stingl; M E van der Rest; K Altendorf; D Molenaar
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

8.  Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility.

Authors:  Hanafiah Alfizah; Awang Hamat Rukman; Ahmad Norazah; Razlan Hamizah; Mohamed Ramelah
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  Response to metronidazole and oxidative stress is mediated through homeostatic regulator HsrA (HP1043) in Helicobacter pylori.

Authors:  Igor N Olekhnovich; Serhiy Vitko; Meaghan Valliere; Paul S Hoffman
Journal:  J Bacteriol       Date:  2013-12-02       Impact factor: 3.490

10.  In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.

Authors:  Morris O Makobongo; Tchelet Kovachi; Hanan Gancz; Amram Mor; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.